Genotypic Technology Company Profile
Genotypic is the First and leading Genomics company in India. Established in 1998, it envisions to becoming a global leader providing affordable high-end Genomics and Bioinformatics services and solutions to customers through continuous innovation, diligence, commitment and ingenious approaches.
Having Pioneered Microarrays and Next Generation Sequencing Services in India with well equipped cutting edge Genomics and Bioinformatics tools, Genotypic offers customized "one-stop solutions" to address complex questions in Biology. Genotypic is well known for innovatively combining genomics platforms and analysis methods to offer real value to Biology Researchers in a short time and affordable
cost. Genotypic is empowered with scientists from diverse background like Molecular biology, Biotechnology, Biochemistry, Microbiology, Information Technology.
Being a company driven by continuous Research and Development in life sciences, we have streamlined complex laboratory practices related to molecular biology, developed computational tools and software that will enable user friendly biological data mining. Successfully completed more than 1000 Microarray and over 500 Next generation sequencing projects to clients in India and worldwide. Genotypic's contribution in the last decade, has been in areas like Cancer genomics, AgriGenomics, Bovine/ Cattle Genomics, Toxicogenomics, Clinical genomics, Bacterial in research domains like Cancer genomics, Agrigenomics, Bovine genomics, clinical genomics, Biomarker discovery, epigenetics, bacterial biosensors, drug target discovery, vaccine research, translational medicine, toxicogenomics, metagenomics, personalized medicine and many more..
Highlights of Genotypic
- First in world to be certified by Agilent Technologies for 3 major microarray applications – Gene Expression, ChIP on Chip and aCGH.
- First India’s Certified Service Provider for Ion Torrent PGM.
- ISO 9001-2008 certified for providing high quality Genomics and Bioinformatics services and solutions.
- Received SAP ACE 2010 award for Best Run companies for implementing SAP on-demand
- First in the world to design whole genome aCGH Microarray for Arabidopsis, Bovine, Dog and Drosophila.
- First in world to release well annotated Microarrays for Banana, Tobacco, Eucalyptus, Tea, Tomato, Guinea pig and Rabbit.
- First in world to design whole genome methylation array for Rat & Chick.
- Released well annotated Microarrays for Guinea pig, Tobacco, Eucalyptus, Antirrhinum and many organisms.
Location
#2/13, Balaji Complex
80 Feet Road, RMV 2nd Stage
Bangalore
Maharashtra
560094
India
Contact
Phone: +91-80-40538200
Fax: +91-80-23516555
Email: genomics@genotypic.co.in
News Articles
CAMBRIDGE, Mass., April 24, 2013 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of hum...
Idenix Pharmaceuticals, Inc. (IDIX) Bank of America Merrill Lynch Health Care Conference Call May 15, 2013 2:20 PM ET Executives Ron Renaud – President and CEO Analysts Rachel McMinn – Ban...
Resistance benefits for Achillion's NS5A inhibitor as combos progress for HCV
The US firm Achillion Pharmaceuticals has positive proof-of-concept data that justify further development of its second-generation, pan-genotypic NS5A inhibitor ACH-3102 to treat hepatitis C virus (HC...
Federal Guidelines Recommend New HIV Testing Method
MADISON, N.J., March 27, 2013 /PRNewswire/ -- A new test based on gene sequencing may be used to assess a patient's suitability for treatment with CCR5 antagonists, a class of HIV antiretroviral...
Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance
The authors review new tools for studying the evolution of antibiotic resistance, including approaches to evolve resistance in the laboratory and analysis of clinical samples. Insights into pathways o...
Collaboration With Merck’s Protease Inhibitor The Fourth HCV Tie-Up For Bristol’s Daclatasvir
Merck and Bristol will run a Phase II trial testing daclatasvir, an NS5A replication complex inhibitor, in tandem with MK-5172, Merck’s potentially pan-genotypic protease inhibitor in a non-exclusiv...
Veteran Biotech Investor Kevin Kinsella Talks Genes, Drugs, and Musicals
U-T San Diego | Kevin Kinsella, the veteran San Diego-based biotech investor, is as much about musicals and social networking these days as personalized medicine. "Getting your complete genome sequen...
Drugs and Medications
Selzentry [Pfizer Laboratories Div Pfizer Inc]
These highlights do not include all the information needed to use SELZENTRY safely and effectively. See full prescribing information for SELZENTRY. SELZENTRY (maraviroc) TabletsInitial U.S. Approval:...
Fortovase®(saquinavir)soft gelatin capsules [Roche Laboratories Inc.]
FORTOVASE®(saquinavir)SOFT GELATIN CAPSULES
EPZICOM (abacavir sulfate and lamivudine)Tablets
Epzicom [Physicians Total Care, Inc.]
EPZICOM (abacavir sulfate and lamivudine)Tablets
Epzicom [State of Florida DOH Central Pharmacy]
EPZICOM (abacavir sulfate and lamivudine)Tablets
PubMed Articles
Intraspecific genotypic richness and relatedness predict the invasibility of microbial communities.
Biological invasions can lead to extinction events in resident communities and compromise ecosystem functioning. We tested the effect of two widespread biodiversity measurements, genotypic richness an...
Objectives: To assess the performance of genotypic algorithms for predicting CXCR4-using virus with enhanced sensitivity Trofile(TM) HIV co-receptor tropism assay (ES-Trofile(TM)) as reference, and to...
BACKGROUND: Several decision support systems have been developed to interpret HIV-1 drug resistance genotyping results. This study compares the ability of the most commonly used systems (ANRS, Rega, a...
Interferon (IFN) response rate in hepatitis C virus (HCV) patients has been varied with genotypes. In this study, we investigated the effects of HCV NS5A protein on IFN resistance and compared the gen...
Ecology Letters (2011) ABSTRACT: Intra- and interspecific plant-plant interactions are fundamental to patterns of community assembly and to the mixture effects observed in biodiversity studies. Althou...
Clinical Trials
The investigators seek to determine whether Virco®TYPE HIV-1 provides benefits equivalent to those provided by local expert review. The investigators propose that clinic patients of the R...
GILT Docetaxel - Non-Small Cell Lung Cancer
Primary Objective: - To compare response rate between genotypic groups and control group. Secondary Objective: - To determine the safety, time to treatment failure and survi...
Trichomoniasis: Genotype and Phenotype Correlations in African American Women
The hypothesis to be tested in this trial is that the different epidemiologic (including racial differences) and phenotypic manifestations exhibited by Trichomonas clinical isolates during...
Primary objective: Evaluation of the efficacy of TDF+3TC+EFV versus TDF+EFV QD to maintain plasma HIV-1 RNA BLQ (< 50 copies/mL) (c/mL) at 48 weeks (W48) Main Secondary objectives:...
The Detection of Drug-Resistant HIV-1 in Taiwan
To assess the HIV resistance rate to variable antiretroviral agents in Taiwan, especially in patients with treatment failure, and to know the correlation between the drug resistance patter...
Companies
Genotypic is the First and leading Genomics company in India. Established in 1998, it envisions to becoming a global leader providing affordable high-end Genomics and Bioinformatics services and sol...
More Information about "Genotypic Technology" on BioPortfolio
We have published hundreds of Genotypic Technology news stories on BioPortfolio along with dozens of Genotypic Technology Clinical Trials and PubMed Articles about Genotypic Technology for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Genotypic Technology Companies in our database. You can also find out about relevant Genotypic Technology Drugs and Medications on this site too.
